The commercial environment of the vasoconstrictor medication is defined by several unique business insights that guide strategic manufacturing and distribution decisions. The primary insight is the fact that demand is driven almost entirely by clinical need and established protocols, making the critical care specialist and the hospital formulary committee the key commercial...